Pramlintide, the first generation (1990s) In the 1990s, the pharmaceutical company Amylin Pharmaceuticals developed Pramlintide , a modified amylin with three proline substitutions at positions 25, 28 and 29
Found in human blood plasma, it declines with age
Follow smart dosing strategies, cycle responsibly, and monitor how your body responds
That said, we want patients to hear this clearly: GHK-Cu is not a cure-all
It acts as a detoxifying agent, skin lightener, and wellness booster and helps to correct blemishes, scars, pigmentation, dark spots, and other signs of aging